Skip to content

Intervention of cognitive reassessment on rumination thinking in breast cancer patients during postoperative chemotherapy

Effect of cognitive reappraisal on ruminative thought in breast cancer patients with postoperative chemotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN64054642
Enrollment
64
Registered
2024-09-03
Start date
2022-06-01
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer Cancer

Interventions

Participants were randomly divided into a control group and a cognitive reappraisal group according to a random number table. In order to avoid contamination between the two groups, both the control g
After discharge, patients will receive routine telephone follow-up
The intervention duration is four chemotherapy cycles. On the basis of the control group, patients in the cognitive reappraisal group entered the activity room at the same intervention time to receive

Sponsors

Soochow University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Female patients diagnosed with breast cancer by pathological report 2. Age 18 years and above 3. Tumor Node Metastasis (TNM) stages I-III 4. First four cycles of postoperative adjuvant chemotherapy 5. Understanding one's own disease diagnosis without the need for protective medical care 6. Having certain abilities in reading, writing, comprehension, and language expression 7. Informed consent and voluntary participation in this study

Exclusion criteria

Exclusion criteria: 1. Individuals with severe physical diseases such as other malignant tumors 2. Individuals with organic brain diseases or combined with other mental disorders 3. Patients who have recently participated in other psychological interventions or received psychotherapy

Design outcomes

Primary

MeasureTime frame
Ruminative thought is measured using a Ruminative Responses Scale (RRS) at baseline, 4, 7, and 10 weeks

Secondary

MeasureTime frame
Depression is measured using a Self-Rating Depression Scale (SDS) at baseline, 4, 7, and 10 weeks

Countries

China

Contacts

Public ContactYueyue Zhang
15850130176@163.com+86 (0)15850130176

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026